The proposed revisions take into account current knowledge of the link between diet and chronic diseases such as obesity, diabetes and heart disease. "The purpose of the nutrition panel is to support consumers to choose healthy diets in accordance with the Dietary Guidelines for Americans," Michael Taylor, the FDA's deputy commissioner for foods and veterinary medicine, said at a Thursday afternoon news conference. "It is also important that the labels stay up-to-date," he added. Taylor said he was confident the food industry was onboard with the changes to food labels. "I think there is broad support for this process and the approach we are taking," he said. Highlights of the proposal include: Calorie content and serving sizes would be featured more prominently to help address obesity, "one of the most important public health problems facing our country," Taylor said.
Gang Hu Of The Pennington Biomedical Research Center In Baton Rouge, La., Analyzed Data Gathered From Almost 11,000 Men And More Than 19,000 Women.
One of the challenges in diabetes control is keeping blood sugar levels low while avoiding hypoglycemia, or dangerously low blood sugar. "The clinical data suggests these are very [effective] drugs that don't cause hypoglycemia," said Ratner. Also, unlike some diabetes drugs that promote harmful weight gain, GLP-1 agonists cause weight loss, while DPP-4 inhibitors are weight neutral. Weight loss often improves diabetes. After the drugs received approval, the FDA and EMA received reports of pancreatitis (inflammation of the pancreas) and pancreatic cancer in people taking the drugs. "There was a disproportionate reporting of these adverse events detected," said the lead author of the safety assessment, Dr. Amy Egan, deputy director for safety in the FDA's division of metabolism and endocrinology products. However, the risks of pancreatitis and pancreatic cancer are already elevated in people with type 2 diabetes, said Egan.
Study Sees No Evidence Linking Diabetes Drugs With Pancreatic Cancer news
"As women go through menopause, the loss of protective estrogen allows for the risk factors of cardiovascular disease -- such as diabetes -- to wreak havoc on the arteries," explained Steinbaum, who was not involved in the new study. According to background information in the study, women living in developed countries are more likely to die from a stroke than their male peers. In the United States, women accounted for nearly 60 percent of stroke deaths in 2010, the study authors said. In the study, a team led by Dr. Gang Hu of the Pennington Biomedical Research Center in Baton Rouge, La., analyzed data gathered from almost 11,000 men and more than 19,000 women. During an average follow-up of almost seven years, nearly 3,000 cases of stroke occurred among the participants. Depending on their blood sugar control, women with diabetes were 19 to 42 percent more likely to suffer a stroke than those without diabetes. The researchers also found that risk of stroke among women with diabetes was much higher for those aged 55 and older, compared to younger women.